RNA polymerase I-driven minigenome system for Ebola viruses.
about
The Ebola virus glycoprotein contributes to but is not sufficient for virulence in vivoArenavirus reverse genetics: new approaches for the investigation of arenavirus biology and development of antiviral strategiesNeglected filovirusesProgress towards the treatment of Ebola haemorrhagic fever.Reverse genetics technology for Rift Valley fever virus: current and future applications for the development of therapeutics and vaccines.Production of infectious hepatitis C virus by using RNA polymerase I-mediated transcription.Minigenome-based reporter system suitable for high-throughput screening of compounds able to inhibit Ebolavirus replication and/or transcription.Rescue of recombinant Marburg virus from cDNA is dependent on nucleocapsid protein VP30Filovirus replication and transcription.A cell-based screening system for influenza A viral RNA transcription/replication inhibitorsRecovery of an arenavirus entirely from RNA polymerase I/II-driven cDNAInfection of naive target cells with virus-like particles: implications for the function of ebola virus VP24.Novel Arenavirus Entry Inhibitors Discovered by Using a Minigenome Rescue System for High-Throughput Drug Screening.Ebolavirus classification based on natural vectors.The Ebola virus ribonucleoprotein complex: a novel VP30-L interaction identifiedGeneration of biologically contained Ebola viruses.Development of a minigenome system for Andes virus, a New World hantavirus.Minigenomes, transcription and replication competent virus-like particles and beyond: reverse genetics systems for filoviruses and other negative stranded hemorrhagic fever virusesThe marburg virus 3' noncoding region structurally and functionally differs from that of ebola virus.The L-VP35 and L-L interaction domains reside in the amino terminus of the Ebola virus L protein and are potential targets for antivirals.Fibroblastic reticular cells and their role in viral hemorrhagic fevers.Reverse genetics systems as tools for the development of novel therapies against filoviruses.Duck hepatitis A virus serotype 1 minigenome: a model for studying the viral 3'UTR effect on viral translation.An RNA polymerase II-driven Ebola virus minigenome system as an advanced tool for antiviral drug screening.Generation of Recombinant Ebola Viruses Using Reverse Genetics.Establishment and characterization of plasmid-driven minigenome rescue systems for Nipah virus: RNA polymerase I- and T7-catalyzed generation of functional paramyxoviral RNA.Virology. Mutation rate and genotype variation of Ebola virus from Mali case sequences.Inside the Cell: Assembly of Filoviruses.Ebola virus VP35-VP40 interaction is sufficient for packaging 3E-5E minigenome RNA into virus-like particles.Minigenome Systems for Filoviruses.Construction & establishment of two minigenome rescue systems for Chandipura virus driven by recombinant vaccinia virus expressing T7 polymerase.Rapid determination of ebolavirus infectivity in clinical samples using a novel reporter cell line.
P2860
Q21131393-6343CE29-2A13-4B48-A50D-AD42D17A801AQ24599295-B77441E6-17AB-4706-8030-445F66EF8840Q28383265-750B34FA-50C5-45E1-9270-76E1A3A18463Q30230272-EEABCE79-5988-4BF4-BA7F-0265BC90D90BQ33570326-7C8C09E2-9527-48C5-BB58-31A112707A13Q33877391-B1DD58CA-A04F-425F-ADB7-561CA8236125Q33962901-40BF6E77-D146-42E0-AEF8-B44C34152E3DQ34301750-9E6CB147-1BF3-4033-861D-E1D20D4DE5CBQ34375243-9AEE9DFC-EB62-4232-8038-CEC0A003DCB8Q34560792-5E28010C-6329-4CB3-A780-1B26CDCD5E95Q34574914-3AFE4612-8AE7-4448-B368-0A749F0C1048Q34717930-1CB22F4A-C906-4F6D-A16E-1585B192369BQ35652155-F0EBCDC7-6AA4-4F34-AE4B-6564AE8C1385Q35794686-53A1618B-993D-4864-A914-BA281C2BF3E4Q36100550-24FE8A53-AE1A-4E26-95F8-FC79DCD60838Q36446078-0ADCDDE5-5CBB-447E-8A37-2FB19AACB218Q36454591-3108428C-68BC-4883-9FBB-5A861DBED3EBQ36650409-FFE95556-4CF1-4D13-A9A8-4356F5C73985Q37157191-8E14333B-D345-4D38-A9C1-71CAF9FC5462Q37172020-AD836EA1-2418-438D-87BD-AA6799BD3E64Q37463214-145766F6-87EF-434C-8089-2B8B23282466Q38244444-6F7473D6-F50E-468C-8887-2F073DFA55BAQ38818813-C9FA7511-DE16-4403-9DB8-AE1310350174Q40043376-43A13B76-B6F9-4797-8D8A-B6550F8CF5E4Q40054473-02B42521-2564-4220-BA0F-BF420879E838Q40074669-1FF280E6-3B2E-4CC6-97D2-90C24D6D5A32Q40163432-8915152C-6D25-4355-BB74-0EA52E4E9B50Q40164595-89C77991-C5F1-4D64-9D14-496E06F43EF3Q40479218-0B952504-EACB-4033-9E7D-02E51DE78AA2Q41922392-F9DB5255-BF32-4E3B-AC5B-27D212DA3F2FQ41930117-BE77D3B4-EBD4-486B-AA4F-FE6CE70B7CC6Q44105875-9FDAD047-E03C-4B08-A292-BDB22E2EB100
P2860
RNA polymerase I-driven minigenome system for Ebola viruses.
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
RNA polymerase I-driven minigenome system for Ebola viruses.
@ast
RNA polymerase I-driven minigenome system for Ebola viruses.
@en
type
label
RNA polymerase I-driven minigenome system for Ebola viruses.
@ast
RNA polymerase I-driven minigenome system for Ebola viruses.
@en
prefLabel
RNA polymerase I-driven minigenome system for Ebola viruses.
@ast
RNA polymerase I-driven minigenome system for Ebola viruses.
@en
P2093
P2860
P1433
P1476
RNA polymerase I-driven minigenome system for Ebola viruses.
@en
P2093
Allison Groseth
Gülsah Mehmetoglu
Ramon Flick
Steven Theriault
P2860
P304
P356
10.1128/JVI.79.7.4425-4433.2005
P577
2005-04-01T00:00:00Z